{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:19:33Z","timestamp":1793110773064,"version":"4.5.0"},"reference-count":26,"publisher":"Portland Press Ltd.","issue":"11","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:p>In the present study, we have determined the relative frequency of the R46L, I474V and E670G variants in the PCSK9 (protein convertase subtilisin\/kexin type\u00a09) gene and its association with plasma lipid levels and CHD (coronary heart disease) in healthy U.K. men and patients with clinically defined definite FH (familial hypercholesterolaemia). Genotypes were determined using PCR and restriction enzyme digestion in 2444 healthy middle-aged (50\u201361\u00a0years) men from the prospective NPHSII (Second Northwick Park Heart Study), with 275 CHD events (15\u00a0years of follow-up), and in 597 U.K. FH patients from the Simon Broome Register. In the NPHSII healthy men, the R46L genotype distribution was in Hardy\u2013Weinberg equilibrium and the frequency of 46L was 0.010 [95% CI (confidence interval), 0.007\u20130.013], with one man homozygous for the 46L allele. There was significant association of the 46L allele with lower mean (S.D.) total cholesterol [5.74 (1.01)\u00a0mmol\/l for RR compared with 5.26\u00b11.03\u00a0mmol\/l for RL; P=0.001], apolipoprotein B [0.87 (0.24)\u00a0g\/l for RR compared with 0.75 (0.26)\u00a0g\/l for RL; P&amp;lt;0.0001] and low-density lipoprotein cholesterol [4.01 (0.95)\u00a0mmol\/l for RR compared with 3.62 (0.97)\u00a0mmol\/l for RL; P=0.02]) levels, after adjustment for age, general medical practice, smoking, body mass index and systolic blood pressure. As expected, 46L carriers had a low risk of definite or possible CHD [hazard ratio, 0.46 (95% CI, 0.11\u20131.84)], but this was not statistically significant (P=0.27). Two other common PCSK9 variants I474V [V allele frequency, 0.179 (95% CI, 0.17\u20130.19)] and E670G [G allele frequency, 0.034 (CI, 0.03\u20130.04)] were not associated with any significant effects on lipid levels or CHD risk. In FH patients, the frequency of 46L was 0.003 (95% CI, 0.00\u20130.01), which was significantly lower (P=0.037) than the healthy subjects. In the four FH patients carrying 46L, mean untreated total cholesterol levels were not different (P=0.91) in carriers and non-carriers (median, 10.3\u00a0mmol\/l compared with 10.2\u00a0mmol\/l respectively, after adjustment for age, gender and mutation type). In conclusion, the PCSK9 46L allele is more frequent in healthy U.K. men than in FH patients and is strongly associated with a protective plasma lipid profile risk for CHD. Its low frequency (approx. 2% carriers) means that it does not make a major contribution to determining population CHD risk in the U.K.<\/jats:p>","DOI":"10.1042\/cs20070150","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T14:39:46Z","timestamp":1193927986000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["The <i>PCSK9<\/i> gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men"],"prefix":"10.1042","volume":"113","author":[{"given":"Marileia","family":"Scartezini","sequence":"first","affiliation":[{"name":"Department of Medical Pathology, Federal University of Paran\u00e1, Rua Loth\u00e1rio Meissner 3400, Curitiba-Paran\u00e1 80210-170, Brazil"},{"name":"Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hubbart","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros\u00a0A.","family":"Whittall","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie\u00a0A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew\u00a0H.\u00a0W.","family":"Neil","sequence":"additional","affiliation":[{"name":"Division of Public Health & Primary Health Care, University of Oxford, Oxford OX3 7LF, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve\u00a0E.","family":"Humphries","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, London WC1E 6JJ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2021120120444532600_B1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"2021120120444532600_B2","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.0409736102","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021120120444532600_B3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddl077","article-title":"Effect of mutations in the PCSK9 gene on the cell surface LDL receptors","volume":"15","author":"Cameron","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021120120444532600_B4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"2021120120444532600_B5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"2021120120444532600_B6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"key":"2021120120444532600_B7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021120120444532600_B8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"2021120120444532600_B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10038-003-0114-3","article-title":"Genetic variants in PCSK9 affect the cholesterol level in Japanese","volume":"49","author":"Shioji","year":"2004","journal-title":"J. Hum. Genet."},{"key":"2021120120444532600_B10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","article-title":"A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis","volume":"45","author":"Chen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021120120444532600_B11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.0000204337.81286.1c","article-title":"Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy","volume":"26","author":"Berge","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021120120444532600_B12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0038-1653729","article-title":"The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men","volume":"73","author":"Miller","year":"1995","journal-title":"Thromb. Haemostasis"},{"key":"2021120120444532600_B13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0038-1650364","article-title":"Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb. Haemostasis"},{"key":"2021120120444532600_B14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"key":"2021120120444532600_B15","article-title":"The Minnesota Code Manual of Electrocardiographic Findings: standards and procedures for measurement and classification","volume-title":"Boston","author":"Prineas","year":"1982"},{"key":"2021120120444532600_B16","article-title":"Committee on Chronic Bronchitis and Questionaire on Respiratory Symptoms","author":"Medical Research Council","year":"1995"},{"key":"2021120120444532600_B17","article-title":"Myocardial Infarction Community Registers: Results of a WHO International Collaborative Study Coordinated by the Regional Office for Europe","author":"World Health Organization","year":"1976"},{"key":"2021120120444532600_B18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"The risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committee on behalf of The Simon Broome Register Group","year":"1991","journal-title":"Br. Med. J."},{"key":"2021120120444532600_B19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","article-title":"Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk","volume":"43","author":"Humphries","year":"2006","journal-title":"J. Med. Genet."},{"key":"2021120120444532600_B20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.ejhg.5200633","article-title":"A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom","volume":"9","author":"Heath","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"2021120120444532600_B21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/abio.1994.1507","article-title":"Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose","volume":"222","author":"Day","year":"1994","journal-title":"Anal. Biochem."},{"key":"2021120120444532600_B22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"2021120120444532600_B23","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"ii","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"2021120120444532600_B24","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.ATV.13.10.1460","article-title":"Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations","volume":"13","author":"Kotze","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"2021120120444532600_B25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0009-8981(99)00097-2","article-title":"Apolipoprotein E and atherosclerosis: insight from animal and human studies","volume":"286","author":"Davignon","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"2021120120444532600_B26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/hmg\/5.9.1325","article-title":"Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism","volume":"5","author":"Webb","year":"1996","journal-title":"Hum. Mol. Genet."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/113\/11\/435\/438209\/cs1130435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/113\/11\/435\/438209\/cs1130435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T21:24:01Z","timestamp":1638393841000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/113\/11\/435\/68300\/The-PCSK9-gene-R46L-variant-is-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20070150","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}